35 related articles for article (PubMed ID: 8808314)
1. Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection.
Hakamata M; Takihara H; Iwamoto T; Tamaru A; Hashimoto A; Tanaka T; Kaboso SA; Gebretsadik G; Ilinov A; Yokoyama A; Ozeki Y; Nishiyama A; Tateishi Y; Moro H; Kikuchi T; Okuda S; Matsumoto S
Sci Rep; 2020 Oct; 10(1):17997. PubMed ID: 33093577
[TBL] [Abstract][Full Text] [Related]
2. Resistance of Mycobacterium tuberculosis to antibiotics in Lao PDR: first multicentric study conducted in 3 hospitals.
Iem V; Somphavong S; Buisson Y; Steenkeste N; Breysse F; Chomarat M; Sylavanh P; Nanthavong P; Rajoharison A; Berland JL; Paboriboune P
BMC Infect Dis; 2013 Jun; 13():275. PubMed ID: 23782980
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant tuberculosis.
Lemos AC; Matos ED
Braz J Infect Dis; 2013; 17(2):239-46. PubMed ID: 23477764
[TBL] [Abstract][Full Text] [Related]
4. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.
Bergval IL; Schuitema AR; Klatser PR; Anthony RM
J Antimicrob Chemother; 2009 Sep; 64(3):515-23. PubMed ID: 19578178
[TBL] [Abstract][Full Text] [Related]
5. Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.
Abe C; Kobayashi I; Mitarai S; Wada M; Kawabe Y; Takashima T; Suzuki K; Sng LH; Wang S; Htay HH; Ogata H
J Clin Microbiol; 2008 Jul; 46(7):2263-8. PubMed ID: 18508939
[TBL] [Abstract][Full Text] [Related]
6. AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.
Sherman DR; Mdluli K; Hickey MJ; Barry CE; Stover CK
Biofactors; 1999; 10(2-3):211-7. PubMed ID: 10609885
[TBL] [Abstract][Full Text] [Related]
7. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
Zhang Y; Heym B; Allen B; Young D; Cole S
Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
[TBL] [Abstract][Full Text] [Related]
8. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.
Ahmad S; Mokaddas E
Int J Antimicrob Agents; 2004 May; 23(5):473-9. PubMed ID: 15120726
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between INH-resistance and katG mutation in M. tuberculosis].
Zhang Z; Ma Y; Cheng S
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):346-9. PubMed ID: 9596816
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid].
Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM
Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428
[TBL] [Abstract][Full Text] [Related]
12. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.
Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S
Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.
Heym B; Saint-Joanis B; Cole ST
Tuber Lung Dis; 1999; 79(4):267-71. PubMed ID: 10692996
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
